All Articles
Listen as a nurse navigator discusses ovarian function suppression (OFS) and the subsequent impact of OFS on premenopausal women with breast cancer. Read More ›
Breast cancer treatments pose significant fertility risks, emphasizing the importance of fertility counseling and preservation techniques, as highlighted by a study on young breast cancer patients. Read More ›
Adding aromatase inhibitors to ovarian function suppression significantly improves invasive disease-free survival and underscores the importance of individualized treatment decisions based on clinicopathological factors. Read More ›
Using these 5 strategies will contribute to timely patient care and efficient
office operations. Read More ›
Several useful techniques can help develop effective office procedures and
improve patient care. Read More ›
Recognizing the complexities of treatment with oral medications is an important step toward successful outcomes. Read More ›
The FDA recently announced the publication of an article reviewing 50 years of the FDA’s experience with clinical research related to the use of cannabis in drug development. Read More ›
The addition of pembrolizumab to standard-of-care FLOT (docetaxel, oxaliplatin, leucovorin, and 5-fluorouracil) prolongs pathologic complete response (pCR) and event-free survival (EFS) in patients with resectable gastric and gastroesophageal junction (G/GEJ) adenocarcinoma. Read More ›
The addition of durvalumab and bevacizumab to transarterial chemoembolization (TACE) significantly improved progression-free survival (PFS) in patients with unresectable hepatocellular carcinoma (HCC) eligible for embolization. Read More ›
The combination of cabozantinib and atezolizumab improved radiographic progression-free survival (rPFS) versus a switch to a second novel hormonal agent (NHT) in patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease progressed on a first NHT, according to findings from the phase 3 CONTACT-02 trial. Read More ›